Thyrocare Technologies Limited (BOM:539871)
India · Delayed Price · Currency is INR 579.15
-11.05 (-1.87%)
At close: Jul 31, 2026
Thyrocare Technologies Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Thyrocare Technologies stock has a consensus rating of "Strong Buy" and an average price target of ₹649.00. The average 1-year stock price forecast is 12.06% higher than the current stock price, while the lowest is ₹615.00 (+6.19%) and the highest is ₹680.00 (+17.41%).
Price Target: ₹649.00 (+12.06%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Thyrocare Technologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Jan '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 4 | 5 | 5 |
Financial Forecast
Revenue This Year
9.97B
from 8.29B
Increased by 20.24%
Revenue Next Year
11.73B
from 9.97B
Increased by 17.69%
EPS This Year
12.89
from 10.54
Increased by 22.30%
EPS Next Year
15.86
from 12.89
Increased by 23.07%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.